USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/28795
Title: Light therapy for seasonal affective disorder (sad): a meta analysis of efficacy
Authors: Thayyil Ayisha
Issue Date: 2024
Publisher: Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova
Citation: Thayyil Ayisha. Light therapy for seasonal affective disorder (sad): a meta analysis of efficacy. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 390. ISBN 978-9975-3544-2-4.
Abstract: Introduction. Affective Disorder is a growing concern in mental health, and this study explores the effectiveness of light therapy. This meta-analysis delves into the efficacy of light therapy as a treatment for SAD. The research illuminates the diverse facets of SAD and its response to light therapy. Aim of study. This study explores dynamics of Seasonal Affective Disorder, emphasizing its connection with seasonal changes and the resulting psychological impact of depression. Going beyond conventional approaches, it aims to understand how light therapy alleviates associated depressive symptoms. Methods and materials. The research is conducted from sources like Google Scholar and ScienceDirect. Inclusion criteria prioritize studies specifically focused on light therapy for SAD. Results. To determine the efficacy of light therapy for Seasonal Affective Disorder, a metaanalysis of 19 trials' data was carried out by researchers. With a standardized mean difference for depression ratings of -0.37 and a risk ratio for treatment response of 1.42, bright light therapy appears to be superior to placebo. A study presented an innovative perspective by investigating exposure to outdoor light as a potential adjunct or alternative for traditional artificial light therapy for SAD. Interestingly, using strong placebo controls to compare white and green light treatments highlights the difficulties in distinguishing therapeutic benefits from placebos. Furthermore, a study concentrating on short-wavelength (blue) light treatment shows that it is more effective than dimmer red light for reducing major depressive disorder symptoms in a seasonal pattern. The metaanalysis contributes valuable insights to the evolving understanding of SAD treatment efficacy and highlights the need for larger, high-quality clinical trials to further substantiate these findings. Conclusion. This meta-analysis underscores the significance of light therapy as a viable treatment for SAD, providing valuable insights into its efficacy. The examination of existing research enhances our understanding of the role light therapy plays in addressing the psychological aspects of SAD, paving the way for informed interventions and future studies in this domain. the effectiveness of light therapy. This meta-analysis delves into the efficacy of light therapy as a treatment for SAD. The research illuminates the diverse f acets of SAD and its response to light therapy. Aim of study. This study explores dynamics of Seasonal Affective Diso rder, emphasizing its connection with seasonal changes and the resulting psyc hological impact of depression. Going beyond conventional approaches, it aims to understand how li ght therapy alleviates associated depressive symptoms. Methods and materials. The research is conducted from sources like Google Schola r and ScienceDirect. Inclusion criteria prioritize studies specifically focused on light therapy for SAD. Results. To determine the efficacy of light therapy for Season al Affective Disorder, a metaanalysis of 19 trials' data was carried out by researchers . With a standardized mean difference for depression ratings of -0.37 and a risk ratio for treatment response of 1.42, bright light therapy appears to be superior to placebo. A study presented an innovative perspective by investigating exposure to outdoor light as a potential adjunct or alternat ive for traditional artificial light therapy for SAD. Interestingly, using strong placebo controls to co mpare white and green light treatments highlights the difficulties in distinguishing therapeutic bene fits from placebos. Furthermore, a study concentrating on short-wavelength (blue) light trea tment shows that it is more effective than dimmer red light for reducing major depressive disorder sympt oms in a seasonal pattern. The metaanalysis contributes valuable insights to the evolving underst anding of SAD treatment efficacy and highlights the need for larger, high-quality clinical tri als to further substantiate these findings. Conclusion. This meta-analysis underscores the significance of light therapy as a viable treatment for SAD, providing valuable insights into its efficacy. The examination of existing research enhances our understanding of the role light therapy plays i n addressing the psychological aspects of SAD, paving the way for informed interventions and future st udies in this domain.
metadata.dc.relation.ispartof: MedEspera 2024
URI: https://ibn.idsi.md/collection_view/3104
http://repository.usmf.md/handle/20.500.12710/28795
ISBN: 978-9975-3544-2-4
Appears in Collections:MedEspera 2024

Files in This Item:
File Description SizeFormat 
MEsp24_390.pdf348.72 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback